Beraud Jill — SEC insider filings

SEC reporting owner CIK 1520061. 37 insider filings on record with FilingPulse; latest filed 2026-11-06.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2021-03-02 to 2026-11-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LEVI STRAUSS & CO (LEVI)Director31——52
Revance Therapeutics, Inc. (RVNC)Director6——11

Insider filings — Beraud Jill

FiledFormIssuerReported transactionsSource
2026-11-064LEVI STRAUSS & CO (LEVI)Grant/award (A): 57 @ $0 · Grant/award (A): 97 (derivative) @ $0EDGAR
2026-08-074LEVI STRAUSS & CO (LEVI)Grant/award (A): 54 @ $0 · Grant/award (A): 92 (derivative) @ $0EDGAR
2026-05-084LEVI STRAUSS & CO (LEVI)Grant/award (A): 50 @ $0 · Grant/award (A): 86 (derivative) @ $0EDGAR
2026-04-244LEVI STRAUSS & CO (LEVI)Grant/award (A): 8,381 @ $0EDGAR
2026-02-274LEVI STRAUSS & CO (LEVI)Grant/award (A): 75 @ $0 · Grant/award (A): 89 (derivative) @ $0EDGAR
2025-11-064LEVI STRAUSS & CO (LEVI)Grant/award (A): 85 @ $0 · Grant/award (A): 101 (derivative) @ $0EDGAR
2025-08-124LEVI STRAUSS & CO (LEVI)Grant/award (A): 82 @ $0 · Grant/award (A): 97 (derivative) @ $0EDGAR
2025-05-124LEVI STRAUSS & CO (LEVI)Grant/award (A): 88 @ $0 · Grant/award (A): 104 (derivative) @ $0EDGAR
2025-04-254LEVI STRAUSS & CO (LEVI)Conversion (C): 108,679 @ $0 · Grant/award (A): 11,690 @ $0 · Conversion (C): 108,679 (derivative) @ $0EDGAR
2025-03-044LEVI STRAUSS & CO (LEVI)Grant/award (A): 56 @ $0 · Grant/award (A): 99 (derivative) @ $0EDGAR
2025-02-064Revance Therapeutics, Inc. (RVNC)Code (U): 28,606 @ $3.65 · Disposition to issuer (D): 15,000EDGAR
2024-11-184LEVI STRAUSS & CO (LEVI)Grant/award (A): 60 @ $0 · Grant/award (A): 106 (derivative) @ $0EDGAR
2024-08-224LEVI STRAUSS & CO (LEVI)Grant/award (A): 52 @ $0 · Grant/award (A): 93 (derivative) @ $0EDGAR
2024-05-284LEVI STRAUSS & CO (LEVI)Grant/award (A): 42 @ $0 · Grant/award (A): 74 (derivative) @ $0EDGAR
2024-05-034Revance Therapeutics, Inc. (RVNC)Grant/award (A): 15,000 @ $0 · Grant/award (A): 23,458 (derivative) @ $0EDGAR
2024-04-264LEVI STRAUSS & CO (LEVI)Grant/award (A): 7,642 @ $0EDGAR
2024-02-274LEVI STRAUSS & CO (LEVI)Grant/award (A): 69 @ $0 · Grant/award (A): 88 (derivative) @ $0EDGAR
2023-11-134LEVI STRAUSS & CO (LEVI)Grant/award (A): 87 @ $0 · Grant/award (A): 112 (derivative) @ $0EDGAR
2023-08-214LEVI STRAUSS & CO (LEVI)Grant/award (A): 88 @ $0 · Grant/award (A): 113 (derivative) @ $0EDGAR
2023-05-224LEVI STRAUSS & CO (LEVI)Grant/award (A): 129 @ $0 · Grant/award (A): 117 (derivative) @ $0EDGAR
2023-05-054Revance Therapeutics, Inc. (RVNC)Grant/award (A): 3,534 @ $0 · Grant/award (A): 5,915 (derivative) @ $0EDGAR
2023-04-214/ALEVI STRAUSS & CO (LEVI)Other (J): 77,410 @ $0 · Other (J): 43,330 @ $0 · Other (J): 77,410 (derivative) @ $0 · Other (J): 43,330 (derivative) @ $0EDGAR
2023-04-214LEVI STRAUSS & CO (LEVI)Grant/award (A): 10,251 @ $0EDGAR
2023-02-274LEVI STRAUSS & CO (LEVI)Grant/award (A): 87 @ $0 · Grant/award (A): 81 @ $0EDGAR
2022-11-234LEVI STRAUSS & CO (LEVI)Grant/award (A): 190 @ $0EDGAR
2022-08-184LEVI STRAUSS & CO (LEVI)Grant/award (A): 152 @ $0EDGAR
2022-05-254LEVI STRAUSS & CO (LEVI)Grant/award (A): 222 @ $0EDGAR
2022-05-134/ARevance Therapeutics, Inc. (RVNC)Grant/award (A): 10,756 (derivative) @ $0EDGAR
2022-05-064Revance Therapeutics, Inc. (RVNC)Grant/award (A): 6,059 @ $0 · Grant/award (A): 11,343 (derivative) @ $0EDGAR
2022-04-224LEVI STRAUSS & CO (LEVI)Grant/award (A): 7,812 @ $0EDGAR
2022-02-284LEVI STRAUSS & CO (LEVI)Grant/award (A): 129 @ $0EDGAR
2021-11-184LEVI STRAUSS & CO (LEVI)Grant/award (A): 81 @ $0EDGAR
2021-09-024LEVI STRAUSS & CO (LEVI)Grant/award (A): 94 @ $0EDGAR
2021-07-194LEVI STRAUSS & CO (LEVI)Grant/award (A): 5,455 @ $0EDGAR
2021-05-264LEVI STRAUSS & CO (LEVI)Grant/award (A): 72 @ $0EDGAR
2021-05-074Revance Therapeutics, Inc. (RVNC)Grant/award (A): 4,013 @ $0 · Grant/award (A): 7,551 (derivative) @ $0EDGAR
2021-03-024LEVI STRAUSS & CO (LEVI)Grant/award (A): 56 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1520061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs